We are live on ! Find out more
ACM

Aster Capital Management Portfolio holdings

AUM $306M
1-Year Est. Return 18%
This Fund
S&P 500
This Quarter Est. Return
+8.36%
1 Year Est. Return
+18%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$441M
AUM Growth
-$98.8M
Cap. Flow
-$107M
Cap. Flow %
-24.13%
Top 10 Hldgs %
14.81%
Holding
1,671
New
470
Increased
188
Reduced
316
Closed
697

Top Buys

Rank Stock Value
1
PLTR icon
Palantir
PLTR
+$12M
2
XOM icon
ExxonMobil
XOM
+$6.52M
3
IYR icon
iShares US Real Estate ETF
IYR
+$5.82M
4
PG icon
Procter & Gamble
PG
+$5.61M
5
PGR icon
Progressive
PGR
+$5.53M

Sector Composition

Rank Sector Weight
1 Financials 17.2%
2 Technology 12.73%
3 Industrials 12.41%
4 Consumer Discretionary 11.3%
5 Healthcare 6.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SFNC icon
851
Simmons First National
SFNC
$3.48B
$5.67K ﹤0.01%
+299
New +$5.63K
AYI icon
852
Acuity Brands
AYI
$10.7B
$5.67K ﹤0.01%
19
-1,123
-98% -$291K
EIG icon
853
Employers Holdings
EIG
$908M
$5.61K ﹤0.01%
119
-17,558
-99% -$847K
FLG
854
Flagstar Bank National Association
FLG
$5.98B
$5.42K ﹤0.01%
511
-709
-58% -$8.1K
KN icon
855
Knowles
KN
$3.44B
$5.37K ﹤0.01%
+305
New +$4.92K
OXM icon
856
Oxford Industries
OXM
$581M
$5.35K ﹤0.01%
+133
New +$6.69K
GRAL
857
GRAIL Inc
GRAL
$3.19B
$5.19K ﹤0.01%
101
-1,704
-94% -$61.7K
GIII icon
858
G-III Apparel Group
GIII
$1.55B
$5.11K ﹤0.01%
228
-210
-48% -$5.29K
PCRX icon
859
Pacira BioSciences
PCRX
$987M
$5.07K ﹤0.01%
+212
New +$5.34K
WBTN
860
WEBTOON Entertainment Inc
WBTN
$1.26B
$5.05K ﹤0.01%
556
-1,001
-64% -$8.68K
AHCO icon
861
AdaptHealth
AHCO
$946M
$5.02K ﹤0.01%
+532
New +$4.69K
AVPT icon
862
AvePoint
AVPT
$2.85B
$5K ﹤0.01%
+259
New +$4.49K
XERS icon
863
Xeris Biopharma Holdings
XERS
$1.42B
$4.98K ﹤0.01%
+1,067
New +$4.89K
INVA icon
864
Innoviva
INVA
$1.52B
$4.98K ﹤0.01%
+248
New +$4.77K
VTOL icon
865
Bristow Group
VTOL
$1.29B
$4.98K ﹤0.01%
151
-4,184
-97% -$126K
YOU icon
866
Clear Secure
YOU
$5.86B
$4.94K ﹤0.01%
178
-21,506
-99% -$548K
PAHC icon
867
Phibro Animal Health
PAHC
$1.45B
$4.93K ﹤0.01%
+193
New +$4.21K
OFG icon
868
OFG Bancorp
OFG
$2.25B
$4.92K ﹤0.01%
115
-21,822
-99% -$874K
TWLO icon
869
Twilio
TWLO
$29.2B
$4.85K ﹤0.01%
+39
New +$4.15K
ADMA icon
870
ADMA Biologics
ADMA
$2.12B
$4.84K ﹤0.01%
+266
New +$5.42K
HRMY icon
871
Harmony Biosciences
HRMY
$2.22B
$4.8K ﹤0.01%
+152
New +$4.89K
HCI icon
872
HCI Group
HCI
$2.28B
$4.72K ﹤0.01%
31
-225
-88% -$34.5K
SPRY icon
873
ARS Pharmaceuticals
SPRY
$529M
$4.68K ﹤0.01%
268
-2,823
-91% -$40.7K
OPK icon
874
Opko Health
OPK
$985M
$4.56K ﹤0.01%
3,453
-15,809
-82% -$21.6K
AZZ icon
875
AZZ Inc
AZZ
$4.61B
$4.54K ﹤0.01%
+48
New +$4.24K

Similar funds

Aster Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Aster Capital Management held 1,671 positions worth $441M, down 18% from $540M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Aster Capital Management withdrew a net $107M in Q2 2025, closing 697 positions and reducing 316 holdings. Its most notable exit was Invesco S&P 500 Equal Weight ETF, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.

Against the trend, Aster Capital Management opened a new position in Palantir worth $13.9M.

  • Aster Capital Management's largest Q2 2025 buy was Palantir: 102,034 shares worth $13.9M.
  • Aster Capital Management added most to ExxonMobil in Q2 2025, an estimated $6.52M increase.
  • Aster Capital Management's biggest Q2 2025 reduction was State Street SPDR S&P Retail ETF, cutting an estimated $5.88M.
  • Aster Capital Management fully exited Invesco S&P 500 Equal Weight ETF in Q2 2025, selling an estimated $13.7M.
  • Aster Capital Management's ten largest holdings make up 15% of its $441M portfolio in Q2 2025.
  • Aster Capital Management opened 470 new positions and closed 697 in Q2 2025.
  • Aster Capital Management's portfolio value fell 18% quarter-over-quarter to $441M.

Based on Aster Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.